Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
29K characters. Original on sec.gov ·
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
| --- | --- |
Statements in this Quarterly Report on Form 10-Q which are not historical facts, so called “forward-looking statements,” are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those detailed in our filings with the Securities and Exchange Commission. See also Part II, Item 1A of this Quarterly Report on Form 10-Q and Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022. Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.
Overview
We are a leading global supplier of automated test equipment and robotics solutions. We design, develop, manufacture and sell automatic test systems and robotics products. Our automatic test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including the consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our robotics products include collaborative robotic arms and autonomous mobile robots (“AMRs”) used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automatic test equipment and robotics products and services include:
| • | semiconductor test (“Semiconductor Test”) systems; |
|---|
| • | storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”); |
|---|
| • | wireless test (“Wireless Test”) systems; and |
|---|
| • | robotics (“Robotics”) products. |
|---|
The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our test products both through direct sales and sales to the customers’ supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.
In the first quarter of 2023, the demand in the mobility and compute segments of our Semiconductor Test business was lower due to end market slowdown in these segments as well as a slower technology transition in one of our largest end-markets. While the depth of the slowdown and the timing of the recovery are uncertain, we expect the ramp of 3 nanometer process technology followed by gate-all-around process technology, increasing multichip packaging, additional device complexity and unit growth will drive additional demand for test over our four year forecast period.
Our Robotics segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms and Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial automation. The market for our Robotics segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (“SMEs”) throughout the world. We expect Robotics sales channel expansion combined with new products to drive growth in the second half of 2023.
In the first quarter of 2023 we met customer demand, in part, through faster than expected recoveries from supply chain constraints. Both our test and robotics businesses may still be influenced by supply constraints during the remainder of 2023, which could impact our revenue and costs. Our second quarter 2023 forecast excludes approximately $25 million of revenue, primarily in our test businesses, due to these continued supply chain constraints. In the first quarter of 2023, inflation had minimal effects on our results.
Our financial statements are denominated in U.S. dollars. While the majority of our revenues are in U.S. dollars, approximately 70 percent of our Robotics revenue is denominated in foreign currencies. In 2022, the strengthening of the U.S. dollar was a factor in lower than forecasted revenues in our Robotics segment. Continued strengthening of the U.S. dollar would negatively affect Robotics revenue growth in 2023.
Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Robotics businesses. We plan to execute on our strategy while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for opportunistic acquisitions.
Table of Contents
Impact of the COVID-19 Pandemic on our Business
The novel coronavirus (COVID-19) pandemic resulted in government authorities implementing numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines, shelter-in-place orders, vaccination and testing mandates, and business limitations and shutdowns. These measures impacted our day-to-day operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. In the first quarter of 2023 the COVID-19 pandemic had significantly less impact on our business than in prior quarters since the start of the pandemic in 2020. However, we are unable to accurately predict the future impact of COVID-19, which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges or new strains or variants of the virus in areas where we do business.
Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of May 5, 2023, the date of issuance of this Quarterly Report on Form 10-Q.
We believe the COVID-19 pandemic and the numerous measures implemented by authorities in response, adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our financial results. In addition, the pandemic disrupted our contract manufacturers and suppliers, and resulted in supply constraints and in short-term cost increases to meet customer demand.
Supply Chain Constraints and Inflationary Pressures
The global supply shortage of electrical components, including semiconductor chips, continued to impact our supply chain in the first quarter of 2023. As a result, we experienced, and expect to continue to experience, increases in our lead times and costs for certain components for certain of our products. In addition, while not material, inflationary pressures contributed to increased costs for product components and wage inflation, impacting our cost of products, gross margin and profit for the quarter. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles. While not material through the first quarter of 2023, in an effort to mitigate these risks, in some cases, we have incurred higher costs due to investment in supply chain resiliency and to secure available inventory or have extended or placed non-cancellable purchase commitments with semiconductor suppliers, which introduces inventory risk if our forecasts and assumptions prove inaccurate. We have also sourced components from additional suppliers and multi-sourced and pre-ordered components and finished goods inventory in some cases in an effort to reduce the impact of the adverse supply chain conditions we have experienced. There is no assurance that these efforts will be successful. Our second quarter 2023 forecast excludes approximately $25 million of revenue, primarily in our test businesses, due to these continued supply chain constraints.
See Part II—Item 1A, “Risk Factors,” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for our risk factors regarding risks associated with both the COVID-19 pandemic and international conflicts.
Critical Accounting Policies and Estimates
We have identified the policies which are critical to understanding our business and our results of operations. There have been no significant changes during the three months ended April 2, 2023 to the items disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, except as noted below.
Critical accounting estimates are complex and may require significant judgment by management. Changes to the underlying assumptions may have a material impact on our financial condition and results of operations. These estimates may change, as new events occur and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.
Preparation of Financial Statements and Use of Estimates
The preparation of consolidated financial statements requires management to make estimates and judgments that affect the amounts reported in the financial statements. Actual results may differ significantly from these estimates under different assumptions or conditions.
Table of Contents
SELECTED RELATIONSHIPS WITHIN THE CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
| For the Three Months Ended | ||||||||
| April 2, | April 3, | |||||||
| 2023 | 2022 | |||||||
| Percentage of revenues: | ||||||||
| Revenues: | ||||||||
| Products | 77 | % | 83 | % | ||||
| Services | 23 | 17 | ||||||
| Total revenues | 100 | 100 | ||||||
| Cost of revenues: | ||||||||
| Cost of products | 32 | 32 | ||||||
| Cost of services | 10 | 8 | ||||||
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) | 42 | 40 | ||||||
| Gross profit | 58 | 60 | ||||||
| Operating expenses: | ||||||||
| Selling and administrative | 24 | 19 | ||||||
| Engineering and development | 17 | 14 | ||||||
| Acquired intangible assets amortization | 1 | 1 | ||||||
| Restructuring and other | — | 2 | ||||||
| Total operating expenses | 43 | 36 | ||||||
| Income from operations | 15 | 25 | ||||||
| Non-operating (income) expense: | ||||||||
| Interest income | (1 | ) | — | |||||
| Interest expense | — | — | ||||||
| Other (income) expense, net | — | 1 | ||||||
| Income before income taxes | 16 | 24 | ||||||
| Income tax provision | 2 | 2 | ||||||
| Net income | 14 | % | 21 | % | ||||
Results of Operations
First Quarter 2023 Compared to First Quarter 2022
Revenues
Revenues by our reportable segments were as follows:
| For the Three Months Ended | ||||||||||||
| April 2, | April 3, | Dollar | ||||||||||
| 2023 | 2022 | Change | ||||||||||
| (in millions) | ||||||||||||
| Semiconductor Test | $ | 415.0 | $ | 482.3 | $ | (67.3 | ) | |||||
| System Test | 74.6 | 118.7 | (44.1 | ) | ||||||||
| Robotics | 89.2 | 103.2 | (14.0 | ) | ||||||||
| Wireless Test | 38.7 | 51.5 | (12.8 | ) | ||||||||
| $ | 617.5 | $ | 755.4 | $ | (137.9 | ) | ||||||
The decrease in Semiconductor Test revenues of $67.3 million, or 14.0%, was driven primarily by lower tester sales in high performance compute processor and mobile applications and lower memory test sales of DRAM memory testers. The decrease in System Test revenues of $44.1 million, or 37.2%, was primarily due to lower sales in Storage Test of system level and hard disk drive testers and lower sales in Defense/Aerospace. The decrease in Robotics revenues of $14.0 million, or 13.6%, was driven primarily by lower demand for collaborative robotic arms and autonomous mobile robots. The decrease in Wireless Test revenues of $12.8 million, or 24.9%, was primarily due to a decrease in connectivity test products.
Table of Contents
Revenues by country as a percentage of total revenues were as follows (1):
| For the Three Months Ended | ||||||||
| April 2, 2023 | April 3, 2022 | |||||||
| Taiwan | 18 | % | 18 | % | ||||
| United States | 18 | 15 | ||||||
| Korea | 12 | 13 | ||||||
| Europe | 12 | 10 | ||||||
| China | 10 | 19 | ||||||
| Japan | 9 | 6 | ||||||
| Singapore | 8 | 4 | ||||||
| Philippines | 5 | 2 | ||||||
| Malaysia | 3 | 5 | ||||||
| Thailand | 3 | 5 | ||||||
| Rest of World | 2 | 3 | ||||||
| 100 | % | 100 | % | |||||
| (1) | Revenues attributable to a country are based on location of customer site. |
|---|
Gross Profit
Our gross profit was as follows:
| For the Three Months Ended | ||||||||||||
| April 2, 2023 | April 3, 2022 | Dollar/Point Change | ||||||||||
| (in millions) | ||||||||||||
| Gross profit | $ | 356.4 | $ | 454.9 | $ | (98.5 | ) | |||||
| Percent of total revenues | 57.7 | % | 60.2 | % | (2.5 | ) |
Gross profit as a percent of revenue decreased by 2.5 points, primarily due to lower volume and product mix in Semiconductor Test and higher inventory reserves.
Selling and Administrative
Selling and administrative expenses were as follows:
| For the Three Months Ended | ||||||||||||
| April 2, 2023 | April 3, 2022 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Selling and administrative | $ | 151.0 | $ | 140.2 | $ | 10.8 | ||||||
| Percent of total revenues | 24.4 | % | 18.6 | % |
The increase of $10.8 million in selling and administrative expenses was primarily due to the charge of $5.9 million recorded in the three months ended April 2, 2023, related to the modification of Teradyne’s chief executive officer’s outstanding equity awards in connection with his retirement and higher spending in Robotics, Semiconductor Test and System Test, partially offset by lower variable compensation.
Table of Contents
Engineering and Development
Engineering and development expenses were as follows:
| For the Three Months Ended | ||||||||||||
| April 2, 2023 | April 3, 2022 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Engineering and development | $ | 105.8 | $ | 108.1 | $ | (2.3 | ) | |||||
| Percent of total revenues | 17.1 | % | 14.3 | % |
The decrease of $2.3 million in engineering and development expenses was primarily due to lower variable compensation, partially offset by higher spending in Robotics.
Restructuring and Other
During the three months ended April 2, 2023, we recorded $2.0 million of severance charges related to headcount reduction of 67 people primarily in Semiconductor Test, Robotics and Corporate.
During the three months ended April 3, 2022, we recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled on March 25, 2022 for $26.7 million.
Interest and Other
| For the Three Months Ended | ||||||||||||
| April 2, 2023 | April 3, 2022 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Interest income | $ | (5.3 | ) | $ | (0.7 | ) | $ | (4.6 | ) | |||
| Interest expense | 1.0 | 1.0 | — | |||||||||
| Other (income) expense, net | 0.1 | 5.2 | (5.1 | ) |
Interest income increased by $4.6 million primarily due to higher interest rates in 2023. Other (income) expense, net decreased by $5.1 million primarily due to changes in unrealized gains/losses on equity securities, from a $2.2 million loss in 2022 to a $2.0 million gain in 2023.
Income (Loss) Before Income Taxes
| For the Three Months Ended | ||||||||||||
| April 2, 2023 | April 3, 2022 | Dollar Change | ||||||||||
| (in millions) | ||||||||||||
| Semiconductor Test | $ | 96.2 | $ | 149.7 | $ | (53.5 | ) | |||||
| System Test | 15.3 | 41.3 | (26.0 | ) | ||||||||
| Wireless Test | 9.4 | 18.6 | (9.2 | ) | ||||||||
| Robotics | (18.5 | ) | (5.1 | ) | (13.4 | ) | ||||||
| Corporate and Other (1) | (5.2 | ) | (24.2 | ) | 19.0 | |||||||
| $ | 97.1 | $ | 180.4 | $ | (83.3 | ) | ||||||
| (1) | Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, legal and environmental fees, severance charges, acquisition related charges and compensation, and an expense for the modification of Teradyne’s former chief executive officer’s outstanding equity awards. |
|---|
The decrease in income before income taxes in Semiconductor Test was driven primarily by lower revenues in compute processor and mobile applications and lower memory test sales of DRAM memory testers. The decrease in income before income taxes
Table of Contents
in System Test was primarily due to lower sales in Storage Test of system level and hard disk drive testers. The decrease in income before taxes in Wireless Test was driven primarily by a decrease in sales of connectivity test products. The decrease in income before taxes in Robotics was driven primarily by lower demand for collaborative robotic arms and autonomous mobile robots. The decrease in loss before income taxes in Corporate and Eliminations was primarily due to legal settlement charges in 2022 related to litigation for the earn-out dispute in connection with the AutoGuide acquisition.
Income Taxes
The effective tax rate for the three months ended April 2, 2023 and April 3, 2022 was 14.0% and 10.2%, respectively. The increase in the effective tax rate from the three months ended April 3, 2022 to the three months ended April 2, 2023 was primarily attributable to a projected shift in the geographic distribution of income, which increases the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions and a decrease in benefit from equity compensation. These increases in expense were partially offset by increases in benefit from the international provisions of the U.S. Tax Cuts and Jobs Act of 2017 and tax credits.
Contractual Obligations
There have been no changes outside of the ordinary course of business to our contractual obligations as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.
Liquidity and Capital Resources
Our cash, cash equivalents and marketable securities balances decreased by $146.1 million in the three months ended April 2, 2023 to $859.0 million.
Operating activities during the three months ended April 2, 2023 provided cash of $19.3 million. Changes in operating assets and liabilities used cash of $106.5 million due to a $1.9 million increase in operating assets and a $104.7 million decrease in operating liabilities.
The increase in operating assets was primarily due to a $23.7 million increase in inventories, a $15.4 million increase in prepayments and other assets due to prepayments to our contract manufacturers, partially offset by a $37.2 million decrease in accounts receivable.
The decrease in operating liabilities was due to a $93.1 million decrease in accrued employee compensation, a $32.7 million decrease in deferred revenue and customer advance payments, and $1.2 million of retirement plan contributions, partially offset by a $12.5 million increase in income taxes, a $9.6 million increase in other accrued liabilities, and a $0.3 million increase in accounts payable.
Investing activities during the three months ended April 2, 2023 used cash of $94.9 million due to $69.3 million used for purchases of marketable securities, and $41.4 million used for purchases of property, plant and equipment, partially offset by $7.9 million and $7.4 million in proceeds from sales and maturities of marketable securities, respectively, and $0.5 million in proceeds from the cancellation of Teradyne owned life insurance policies related to the cash surrender value.
Financing activities during the three months ended April 2, 2023 used cash of $129.5 million due to $93.3 million used for the repurchase of 0.9 million shares of common stock at an average price of $104.88 per share, $19.9 million used for payment related to net settlements of employee stock compensation awards, $17.2 million used for dividend payments, and $15.2 million used for payments of convertible debt principal, partially offset by $16.0 million from the issuance of common stock under employee stock purchase and stock option plans.
Operating activities during the three months ended April 3, 2022 provided cash of $7.5 million. Changes in operating assets and liabilities used cash of $210.2 million. This was due to an $83.6 million increase in operating assets and a $126.6 million decrease in operating liabilities.
The increase in operating assets was due to a $74.3 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $9.5 million increase in inventories, partially offset by a $0.2 million decrease in accounts receivable.
The decrease in operating liabilities was due to a $114.0 million decrease in accrued employee compensation, a $13.8 million decrease in other accrued liabilities, a $7.6 million decrease in income taxes, and $1.3 million of retirement plan contributions, partially offset by a $6.7 million increase in deferred revenue and customer advance payments, and a $3.4 million increase in accounts payable.
Investing activities during the three months ended April 3, 2022 used cash of $82.7 million due to $166.0 million used for purchases of marketable securities and $44.0 million used for purchases of property, plant and equipment, partially offset by $96.7 million and $30.6 million in proceeds from maturities and sales of marketable securities, respectively.
Table of Contents
Financing activities during the three months ended April 3, 2022 used cash of $254.6 million due to $201.5 million used for the repurchase of 1.8 million shares of common stock at an average price of $115.12 per share, $31.0 million used for payment related to net settlements of employee stock compensation awards, $20.7 million used for payments of convertible debt principal, $17.9 million used for dividend payments, partially offset by $16.5 million from the issuance of common stock under employee stock purchase and stock option plans.
In January 2022, Teradyne’s Board of Directors declared a 10% increase in the quarterly cash dividend to $0.11 per share. Dividend payments for the three months ended April 3, 2022 were $17.9 million. In January 2021, Teradyne’s Board of Directors declared a quarterly cash dividend of $0.10 per share. Dividend payments for the three months ended April 4, 2021 were $16.7 million.
In January 2023, our Board of Directors cancelled the 2021 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. We intend to repurchase up to $500.0 million of common stock in 2023 subject to market conditions.
During the three months ended April 2, 2023, we repurchased 0.9 million shares of common stock for $93.3 million at an average price of $104.88 per share. During the three months ended April 3, 2022, we repurchased 1.8 million shares of common stock for $201.5 million at an average price of $115.12 per share.
While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.
On May 1, 2020, we entered into a credit agreement providing a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, the credit agreement was amended to extend the senior secured revolving credit facility to December 10, 2026. On October 5, 2022, the credit agreement was amended to increase the amount of the credit facility to $750.0 million from $400.0 million. As of May 5, 2023, we have not borrowed any funds under the credit facility.
We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the COVID-19 pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.
Equity Compensation Plans
In addition to our 1996 Employee Stock Purchase Program as discussed in Note Q: “Stock-Based Compensation” in our 2022 Annual Report on Form 10-K, we have a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”).
The purpose of the 1996 Employee Stock Purchase Plan is to encourage stock ownership by all eligible employees of Teradyne. The purpose of the 2006 Equity Plan is to provide equity ownership and compensation opportunities in Teradyne to our employees, officers and directors. Both plans were approved by our shareholders.
Recently Issued Accounting Pronouncements
For the three months ended April 2, 2023, there were no recently issued accounting pronouncements that had, or are expected to have, a material impact to our consolidated financial statements.
Previous: Item 1. Financial Statements · Next: Item 3. Quantitative and Qualitative Disclosures about Market Risks